Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Atherton

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Problems in Cancer|November 29, 2005
Combining information across symptom studiesPamela Atherton, Paul Novotny
Medsurg Nursing : Official Journal of the Academy of Medical-Surgical Nurses|September 24, 2008
A prospective descriptive study exploring hope, spiritual well-being, and quality of life in hospitalized patientsTeri Britt Pipe, Ann Kelly, Gail LeBrun, et al.
Supportive Cancer Therapy|July 18, 2008
Phase II Evaluation of Desipramine for the Treatment of Hot FlashesDebra L Barton, Charles L Loprinzi, Pamela Atherton, et al.
American Journal of Clinical Oncology|February 8, 2006
Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?Paul Brown, Matthew M Clark, Pamela Atherton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance)Charles L Loprinzi, Rui Qin, Shaker R Dakhil, et al.
American Journal of Hematology|January 10, 2023
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expressionAref Al-Kali, Raoul Tibes, Pamela Atherton, et al.
Journal of Psychosocial Oncology|November 23, 2007
Role of a medical social worker in improving quality of life for patients with advanced cancer with a structured multidisciplinary interventionJanis J Miller, Marlene H Frost, Teresa A Rummans, et al.
American Journal of Physical Medicine & Rehabilitation|June 10, 2010
Therapeutic exercise during outpatient radiation therapy for advanced cancer: Feasibility and impact on physical well-beingAndrea L Cheville, Jean Girardi, Matthew M Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumorsHenry C Pitot, Joel M Reid, Jeff A Sloan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancerMatthew P Goetz, David Toft, Joel Reid, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Problems in Cancer|November 29, 2005
Combining information across symptom studiesPamela Atherton, Paul Novotny
Medsurg Nursing : Official Journal of the Academy of Medical-Surgical Nurses|September 24, 2008
A prospective descriptive study exploring hope, spiritual well-being, and quality of life in hospitalized patientsTeri Britt Pipe, Ann Kelly, Gail LeBrun, et al.
Supportive Cancer Therapy|July 18, 2008
Phase II Evaluation of Desipramine for the Treatment of Hot FlashesDebra L Barton, Charles L Loprinzi, Pamela Atherton, et al.
American Journal of Clinical Oncology|February 8, 2006
Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?Paul Brown, Matthew M Clark, Pamela Atherton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance)Charles L Loprinzi, Rui Qin, Shaker R Dakhil, et al.
American Journal of Hematology|January 10, 2023
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expressionAref Al-Kali, Raoul Tibes, Pamela Atherton, et al.
Journal of Psychosocial Oncology|November 23, 2007
Role of a medical social worker in improving quality of life for patients with advanced cancer with a structured multidisciplinary interventionJanis J Miller, Marlene H Frost, Teresa A Rummans, et al.
American Journal of Physical Medicine & Rehabilitation|June 10, 2010
Therapeutic exercise during outpatient radiation therapy for advanced cancer: Feasibility and impact on physical well-beingAndrea L Cheville, Jean Girardi, Matthew M Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumorsHenry C Pitot, Joel M Reid, Jeff A Sloan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancerMatthew P Goetz, David Toft, Joel Reid, et al.
Pageof 2